Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from British American Tobacco ( (GB:BATS) ) is now available.
British American Tobacco has announced a transaction involving Jerome Abelman, the Director, Legal and General Counsel, who acquired shares following the exercise of options under the 2020 British American Tobacco 5 Year Sharesave Scheme. The transaction involved the acquisition of 1,249 ordinary shares at a total price of £29,988.49, conducted outside a trading venue on May 8, 2025. This transaction reflects the company’s ongoing commitment to employee share ownership, potentially impacting stakeholder perceptions and aligning managerial interests with shareholder value.
Spark’s Take on GB:BATS Stock
According to Spark, TipRanks’ AI Analyst, GB:BATS is a Neutral.
British American Tobacco’s stock score reflects strong cash flow and dividend yield, appealing to income investors. The company benefits from stable technical trends and strategic deleveraging. However, earnings volatility and high P/E ratio suggest caution. The earnings call indicates cautious optimism despite industry challenges, including regulatory pressures.
To see Spark’s full report on GB:BATS stock, click here.
More about British American Tobacco
British American Tobacco p.l.c. is a leading company in the tobacco industry, primarily focusing on the production and sale of cigarettes and other nicotine products. The company operates globally, with a significant presence in various markets, offering a range of tobacco and nicotine-based products.
Average Trading Volume: 5,663,225
Technical Sentiment Signal: Buy
Current Market Cap: £68.73B
Learn more about BATS stock on TipRanks’ Stock Analysis page.